Marks: FDA Needs Funding To Enhance IT, Postmarket Surveillance

FDA needs more funding -- and potentially legislative help -- from Congress to update its information technology systems and ramp up its use of artificial intelligence to enhance safety surveillance of medical products, including vaccines, biologics center Director Peter Marks says. FDA has asked Congress for funding to support drug and vaccine surveillance and update IT infrastructure, but Marks says it’s not enough to address all of FDA’s IT needs. FDA had already warned Congress in its fiscal 2023 budget...